Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYCC - Cyclacel CEO Spiro Rombotis - Addressing Cancer Resistance (Video)

CYCC - Cyclacel CEO Spiro Rombotis - Addressing Cancer Resistance (Video)

Cyclacel Pharmaceuticals Inc.
  • Cyclacel is a biotech company developing small molecule drugs for treating cancer and other diseases.
  • CEO Spiro Rombotis joined us for a discussion about cancer resistance and clinical trials.
  • Investor updates including recent study of oral Fadraciclib in patients with advanced tumors and aggressive lymphomas.

For further details see:

Cyclacel CEO Spiro Rombotis - Addressing Cancer Resistance (Video)
Stock Information
Company Name: Cyclacel Pharmaceuticals Inc.
Stock Symbol: CYCC
Market: NASDAQ
Website: cyclacel.com
Menu
CYCC CYCC Quote CYCC Short CYCC News CYCC Articles CYCC Message Board
Get CYCC Alerts

News, Short Squeeze, Breakout and More Instantly...